India Tackles Superbug Menace with New Antibiotic Guidelines

The national plan aims to change the way drugs are prescribed

Join Our Community of Science Lovers!

By Roli Srivastava

MUMBAI (Thomson Reuters Foundation) - India, one of the world's biggest consumers of antibiotics, has issued new national guidelines on their use as part of a drive to fight the rise of drug-resistant superbugs.

Superbugs are seen as a growing threat to modern medicine, with the emergence in the past year of infections resistant to even last-resort antibiotics.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


In India, antibiotic-resistant neonatal infections claim the lives of 60,000 newborn babies each year, according to the Review on Antimicrobial Resistance paper published in 2016.

Issued by India's central medical research body - the Indian Council of Medical Research (ICMR) - the guidelines giving directions on antibiotic use, dosage and duration of treatment have been sent to 20 hospitals so far, officials said.

"The idea of issuing these guidelines is to bring about a change in the way antibiotics are prescribed," Kamini Walia, deputy director of ICMR, told the Thomson Reuters Foundation on Tuesday.

"Doctors' education on antibiotic use has so far been limited to what medical representatives of pharmaceutical companies told them. Some hospitals have prescription guidelines, but most don't," Walia added.

The advisory, put together by leading medical experts from across the country, will be revised and reissued once feedback from hospitals starts coming in, officials said.

In the last few years, hospitals in India have recorded infections resistant to last-resort carbapenems and colistin antibiotics in their intensive care units.

The threat of drug-resistant superbugs has prompted the authorities to issue public awareness messages on state-run radio channels cautioning patients against taking antibiotics without a prescription. Many hospitals have also taken part in a program to control infections.

India has had a policy to tackle resistance to antibiotics since 2011 but many hospitals, nursing homes and family doctors continue to over-prescribe antibiotics, fuelling drug resistant infections, medical experts say.

Last month, drug authorities issued a warning to pharmacies against the sale of antibiotics without a prescription after an American woman who had traveled to India died of a rare superbug, according to media reports.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe